Replies to post #7825 on GTC Biotherapeutics (fka GTCB)

[oldberkeley]

>>What's killing this stock isn't their business model, it's how they're handling investor communications and financing. <<

I'd agree with the latter reason but not the former.

The financing does seem counterproductive, to say the least, but hopefully it's going to be explained next week.

As to the investor relations, I think it's another example of small, retail investors under the delusion that they move the market. I make no presumptions about any of the noble stockholders on this fine site, but I honestly don't think Buffett or Soros are here. I have 50k shares; I believe an earlier poster said he had over 100k; who knows how many Dew or others have. But can we really believe that at the most generous the grand total is over one million?

One million out of 164 million shares. That means the management owes us, on this board, about .006 percent of their care and communication. Wouldn't you say that's about what we got?

[oldacct]

I just emailed my feelings of disappointment
to him.

They're probably at the Bull and Bear in the
Waldorf having cocktails preparing for next
weeks meeting. Watch FNB at 5PM maybe we'll
see them sipping martini's on our dime.

[St_armands_man]

I received a call back from Tom Newberry...

(The fact that he called me back is an indication that I own too many shares...)

The call was informative. His key comments included:

1) Nothing has changed from a strategic perspective.
2) They are continuing partnership discussions but felt it was important to not be negotiating with a "dry" (cash poor)balance sheet. This financing buys them time to negotiate on a solid footing.
3) The delay in the partnership process at the end of last year was driven by their talking to more potential partner candidates, late in the process, than had been expected.
4) The financing was contingent upon their getting good top line results. While this indeed happened, the fact that the results got pushed back, and we ended up in a bear market, hurt the financing valuation.

There was nothing on the call to lead me to believe that partner discussions are in trouble. In fact I got the other sense, that there was increased opportunity due to interest from multiple potential partners. The only downside was the incremental time required to work through the process.